LOTEMAX (Bausch & Lomb Incorporated)


Welcome to the PulseAid listing for the LOTEMAX drug offered from Bausch & Lomb Incorporated. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Bausch & Lomb Incorporated
NON-PROPRIETARY NAME: loteprednol etabonate
SUBSTANCE NAME: LOTEPREDNOL ETABONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: OPHTHALMIC
DOSAGE FORM: SUSPENSION/ DROPS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1998-03-09
END MARKETING DATE: 0000-00-00


LOTEMAX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLOTEMAX from Bausch & Lomb Incorporated
LABELER NAME: Bausch & Lomb Incorporated
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 1998-03-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 24208-299_ae27f407-c1da-4141-8281-2c89ef9ec1fa
PRODUCT NDC: 24208-299
APPLICATION NUMBER: NDA020583

Other LOTEPREDNOL ETABONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bausch & Lomb IncorporatedLOTEMAX
Physicians Total Care, Inc.ALREX
STAT Rx USA LLCALREX